Pay in 4 interest-free payments of $6.97 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Injectable glutathione bypasses poor oral bioavailability, delivering the compound directly into the bloodstream for maximum therapeutic effect
It decreases inflammation and helps to repair cellular damage
The peptide demonstrates dual-phase mechanisms: acute phase preservation of ischemic tissue through anti-apoptotic signaling via Akt activation, and chronic phase activation of cardiac progenitor cells (c-kit+ populations) that contribute to myocardial repair through both structural replacement and paracrine support, with studies showing 200% increases in progenitor cell mobilization and cardiac homing
Absence of clinical safety data No Phase 1 clinical safety trial for BPC-157 has been completed and published
Contact us today
In some cases, both may be used together depending on your needs
